This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian historyVANCOUVER, British Columbia, May 16, 2023 PharmAla Biotech Holdings. | May 16, 2023
Nippon Telegraph and Telephone Corporation hereby announces that, at a meeting of its board of directors held today, NTT authorized a stock split of its common stock and a related. | May 12, 2023
EQS-Ad-hoc: PANTAFLIX AG / Key word: Capital Increase
PANTAFLIX AG resolves on capital increase against cash contributions from authorized capital with private placement
12-May-2023 / 15:43. | May 12, 2023
Lyon, May 11, 2023
OL Groupe entered into on May 10,2023, after being authorized to do so by the Board of Directors during its meeting held on May 9, 2023, pursuant to articles L. 225-38 et seq.. | May 11, 2023